http://api.archives-ouvertes.fr/search/?fq=halId_s:hal-01478840&fl=title_s,en_title_s,docid,label_s,en_label_s,docType_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s,producedDate_tdate,producedDateY_i,language_s,fileMain_s&sort=publicationDate_s+desc
authors
- Figarella-Branger Dominique B
- Le Lechapt-Zalcman E
- Tabouret E T
- Jünger Stephanie
- Maues de Paula André
- Bouvier Corinne
- Colin Carole
- Jouvet Anne
- Forest Fabien F
- Andreiuolo Felipe
- Quintin-Roue Isabelle
- Machet Marie-Christine
- Heitzmann Anne
- Milin Serge
- Sevestre Henri
- Godfraind Catherine
- Labrousse François F
- Metellus Philippe
- Scavarda Didier
- Pietsch Torsten T
keywords
- Trisomy 19
- Intracranial
- Clear cell ependymomas
- RelA
- NF kappa B
document type
ART
abstract
Clear cell ependymoma is one of the 4 main histological subtypes of ependymomas defined by the World Health Organization (WHO) classification of tumors of the CNS. DNA methylation profiling can distinguish 4 subgroups of intracranial ependymomas, including supratentorial (ST) ependymomas with Yes-associated protein 1 fusion (YAP1), ST ependymomas with fusion of v-rel avian reticuloendotheliosis viral oncogene homolog A (RELA), posterior fossa ependymomas with balanced genome, and posterior fossa ependymomas with chromosomal instability. In addition, trisomy 19 is a genomic hallmark of ependymomas with rich branching capillaries. However, the relation of histological and molecular subtypes is unclear.
more information